NuVasive soars on estimates for Q4 and 2014

Wed, 01/15/2014 - 1:16pm
Mass Device

Minimally invasive surgical devices maker NuVasive gets some Wall Street love after announcing strong preliminary results for its 4th quarter.

California medical device maker NuVasive Inc. (NSDQ:NUVA) is flying high today after raising its revenue projections for 2013 amid higher-than-expected 4th quarter sales.

The company expects to report $189 million in revenue for Q4, 14% higher year-over-year, and $683 million for fiscal 2013, NuVasive chairman & CEO Alexis Lukianov told an audience at the J.P. Morgan Healthcare conference this morning.

NUVA shares jumped today, trading 9% higher to $36.80 as of about 1:12 p.m. EST.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.